Abstract: Major depression is a common, serious and recurrent disorder that affects 17-20% of the population of the world. The chronic mild stress (CMS) model has been used as an animal model of depression but reflect anhedonia in animals. Present study investigated behavioral, physiological and neurochemical aspects of rats exposed to a CMS procedure. The consumption of sweet food, locomotor activity, body and adrenal gland weight, BDNF protein levels evaluated in hippocampus, cerebrospinal fluid and serum were assessed in rats. Our findings demonstrated decreased in sweet food intake, increase of adrenal gland weight and a decrease of body weight and no changes were observed in BDNF protein levels in serum, cerebrospinal fluid and hippocampus in rats subjected to CMS procedure. Indeed, locomotor activity was not significantly affected. In conclusion, these data reveal that BDNF protein levels were not significantly correlated with the decrease of sweet food consumption observed in CMS exposed animals.
INTRODUCTION
Major depression is a common, serious and recurrent disorder that affects 17-20% of the population of the world and may result in premature death, major social and economic consequences (Kessler et al., 1994) . Major depressive disorder accounts for 4.4% of the total overall global disease burden and a similar prevalence was found in ischemic heart disease (Mann, 2005) . Among persons with major depression, 75-85% has recurrent episodes and 10-30% recovery incompletely and has persistent or residual depressive symptoms throughout the life (Keller et al., 1986; Mueller et al., 1999; Mann, 2005) .
The treatment of depression was revolutionized about a half-century ago with the introduction of the antidepressants. This event marked the beginning of the modern era of depression research, which has sought to identify the neurobiological basis of depression (Nestler et al., 2002) . Important advances have been made, but our understanding of the precise molecular and cellular underpinnings of this complex disorder is in its infancy. Therefore, animal models are useful to provide new insights into the neurobiology and pathophysiology of depression.
The chronic mild stress (CMS) model has been shown to induce lower consumption of sucrose (sweet food) *Address correspondence to this author at the Laboratório de Neurociências, Programa de Pós-Graduação em Ciências da Saúde, Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, SC, Brazil; Fax: +55 48 3443 4817; E-mail: quevedo@unesc.net Received: August 25, 08, Revised: September 9, 08, Accepted: September 12, 08 postulated to reflect anhedonia (the loss of interest or pleasure) in animals, one of the two core symptoms required for diagnosis of a major depressive episode in humans (Katz et al., 1981; Willner et al., 1987; Willner, 1997) . The exposure of rats to CMS also induces changes in hypothalamic-pituitaryadrenal axis, weight body and adrenal glands (Harro et al., 2001) , all these symptoms are consistent with human depression. Abnormalities of the hypothalamic-pituitaryadrenal axis in depressed patients are well described (Gillespie and Nemeroff, 2005) . CMS leads to increased activity of the HPA axis, including adrenal hypertrophy and corticosterone hypersecretion (Vollmayr and Henn, 2003) .
The CMS model is based on intensive labor, space demanding and long stress procedure which consists of exposing animals sequentially to a variety of mild and unpredictable "stressors" (e.g. isolation, water and food deprivation, restraint, forced swimming, flashing light exposure) for a period of 4-6 weeks. The protocol is regarded as being close to model the human situation, consisting more of daily hassles than traumatic events (Wilner, 2005; Grønli et al., 2006) .
It is worth mentioning that the validity of the CMS model has been questioned, since the decrease in sucrose consumption is not consistently observed following the stress procedure among distinct laboratories (Matthews et al., 1995; Forbes et al., 1996; Harris et al., 1997; Hatcher et al., 1997) . Due to this fact, many attempts to develop and/or replicate the original model have allowed that the stress-induced decrease in sucrose consumption varies within experiments, among laboratories, and with animal strains used (Nestler et al., 2002; Grønli et al., 2004) .
The neurotrophin brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and the most widespread growth factor in the brain. BDNF has diverse functions in the adult brain as a regulator of neuronal survival, fast synaptic transmission, and activity-dependent synaptic plasticity (Hashimoto et al., 2004; Blum and Konnerth, 2005; Lewin and Barde, 2006) . Several studies support the hypothesis of BDNF involvement in depression and suggest that depressive disorder induce a marked decrease in plasma BDNF levels (Castren et al., 2007; Lee et al., 2007) . Moreover, literature findings report that BDNF expression is also modified by stress (TapiaArancibia et al., 2004) . In a recent review article, was described changes on hippocampal BDNF mRNA levels, but not in BDNF protein levels, in stressed rats (Martinowich et al., 2005) .
In this context, the present study investigated the effects of chronic mild stress paradigm on behavioral, physiological and neurochemical parameters in rats under our experimental conditions. The measurement of sweet food intake was used as an index of anhedonia-related behavior. Body and adrenal gland weight were evaluated in rats aiming to assess the physiological responses during a CMS situation. Indeed, BDNF protein levels were assessed in hippocampus, cerebrospinal fluid and serum of rats subjected to the CMS paradigm in order to further correlate behavioral and physiological observations with neurochemical findings.
MATERIALS AND METHODS

Animals
Male Wistar rats (3-4 months old, weighting 220-310 g) were obtained from our breeding colony (UNESC). The animals were housed 5 to cage with food and water available ad libitum and they were maintained on a 12-h light/ dark cycle (lights on at 7: 00 am). All experimental procedures were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the Brazilian Society for Neuroscience and Behavior (SBNeC) recommendations for animal care.
Chronic Mild Stress
Chronic mild stress (CMS) protocol was utilized conform the literature (Gamaro et al., 2003) . Rats were divided in two groups: controls and stressed. Controls were kept undisturbed in their home cages during the 40 days of experiment, receiving only ordinary care with daily supports of food and water. By contrast, the stressed group was subjected to a 40-day chronic mild stress paradigm. Individual stressors and length of time applied each day are listed in Table 1 . The following stressors were used: (i) 24 h of food deprivation; (ii) 24 h of water deprivation; (iii) 1-3 h of restraint, as described later, (iv) 1,5-2 h of restraint at 4° C; (v) forced swimming during 10 or 15 min, as described later; (vi) flashing light during 120-210 min; (vii) isolation (2-3 days). Stress was applied at distinct periods everyday, in order to minimize its predictability.
Restraint was carried out by placing the animal in a 25 cm x 7 cm plastic tube and adjusting it with plaster tape on the outside, so that the animal was unable to move. A 1-cm hole at the far end of the tube was present for animal 
Consumption of Sweet Food
After 40 days of treatment, consumption of sweet food was measured in 30 rats (15 controls and 15 stressed). Animals were placed in a lightened rectangular box (40 cm 15 cm 20 cm) with a ceiling, floor, side walls made of wood and divided into 12 equal rectangles by black lines. Ten "Froot Loops" (Kellogg's ® pellets of wheat and corn starch and sucrose) were placed in one extremity of the box. Animals were submitted to five 3-min trials, once a day, in order to become familiarized. After being habituated, animals were exposed to two test sessions, 3 min each, when the number of ingested pellets and the spontaneous locomotor activity (crossings of black lines and rearings) were registered (Gamaro et al., 2003; Vianna et al., 2000) .
Briefly, the consumption of 1/3 or 1/4 of the "Froot Loops" pellet by an animal was considered as one pellet.
Five trial of sweet food consumption were used to assess the anhedonia-like behavior in rats exposed to the CMS paradigm. Three trials (three consecutive days) of sweet food intake were made with the animals 22-h food deprived which were used as a motivating stimulus; however it may also be an acute stressor. Due to this fact, in the last two trials, these tests were made with animals fed ad libitum (Gamaro et al., 2003) .
Body and Adrenal Gland Weight
Body weight was measured at the beginning (1 st day) and at the last day (40 th day) of the chronic mild stress protocol. At the seventh day after consumption of sweet food, rats were anesthetized with a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg) given intraperitoneally. After death, the adrenal gland was removed through laparotomy, and weighted in an analytical balance. Adrenal gland weight was used in this study as an indirect parameter of hypothalamic-pituitaryadrenal axis activation (Katz et al., 1981; Gamaro et al., 2003) .
Neurochemical Analysis
Blood (serum) and cerebrospinal fluid were collected by cardiac puncture and transcutaneous cisternal puncture, respectively, whereas after rats' death, hippocampus were immediately isolated. Serum, cerebrospinal fluid and hippocampus were stored at -80º C for posterior analyses of BDNF protein levels. BDNF levels in were measured by anti-BDNF sandwich-ELISA, according to the manufacturer instructions (Chemicon, USA). Briefly, hippocampus was homogenized in phosphate buffer solution (PBS) with 1 mM phenylmethylsulfonyl fluoride and 1 mM EGTA. The blood was immediately centrifuged at 3000 g for 5 min, and serum was kept frozen at 80 C until assayed. The cerebrospinal fluid was immediately centrifuged at 3000 g for 5 min, and supernatant was kept frozen at 80 C until assayed. Microtiter plates (96-well flat-bottom) were coated for 24 h with the samples diluted 1: 2 in sample diluent. The plates were then washed four times with sample diluent, and a monoclonal anti-BNDF rabbit antibody diluted to 1: 1000 in sample diluent was added to each well and incubated for 3 h at room temperature. After washing, a peroxidase conjugated anti-rabbit antibody (diluted 1: 1000) was added to each well and incubated at room temperature for 1 h. After addition of streptavidinenzyme, substrate and stop solution, the amount of BDNF was determined by absorbance in 450 nm. A standard curve was produced and it ranged from 7.8 to 500 pg/ml of BNDF. This curve was obtained from a direct relationship between Optical Density and BDNF concentration. Total protein was measured by Lowry's method using bovine serum albumin as a standard.
Statistical Analysis
The Statistical Package for the Social Sciences (SPSS) 15.0 was utilized for statistical analyses. All data are expressed as mean ± standard error of the mean of n animals, and have been statistically analyzed with the Student's t-test for unpaired data. P values less than 0.05 were considered statistically significant. Fig. (1A) , CMS group decreased sweet food intake when compared with control group (t=8.208; df=28; p=0.001) . In the open-field test, showed Fig. (1B) , 40-days of chronic unpredictable stressful protocol reduced, but not in a significant manner, the number of crossings (t=1,805; df=27; p=0.082) and rearings (t=1,945; df=27; p=0.062) compared to non-stressed rats.
RESULTS
As depicted in
The effects of the CMS protocol in body and adrenal gland weight were illustrated in Figs. (2A) and (2B), respectively. After the 40-day of CMS protocol, rats displayed decreased body weight in comparison with control group (t=4.442; df=28; p=0.001). By contrast, CMS procedure induced an increase of rat adrenal gland weight compared with nonstressed rats (t=3.119; df=28; p=0.004). Fig. (3) showed that CMS procedure did not modify the availability of BDNF protein levels in the rat hippocampus (t=1.407; df=18; p=0.177), and cerebrospinal fluid (t=1.457; df=13,925; p=0.167) compared to control. In the periphery, the level of BDNF protein in serum of rats exposed to the CMS paradigm was increased, but not in a significant way, compared to control group (t=1.968; df=12; p=0.073).
DISCUSSION
The present study demonstrated that: (1) CMS rat displayed reduced sweet food intake, without significant changes in locomotor activity; (2) CMS rats showed decreased body weight, and increased adrenal gland weight compared to non-stressed rats; (3) concentrations of BDNF protein levels were not altered in hippocampus, and cerebrospinal fluid. However, a non significant increase in the BDNF protein levels in serum was observed in rats exposed to CMS paradigm compared to control.
The CMS paradigm, which was originally described (Willner et al., 1987) , is a model of depression obtained by using chronic unpredictable mild stressors (Wilner, 2005) . In the CMS model, both consumption of and preference for sucrose intake as well as decreased intracranial self stimulation behavior have served as markers of generalized decrease in sensitivity to reward, which behavior is quite related to anhedonia (Willner et al., 1987; Willner, 1997; Vianna et al., 2000; Häidkind et al., 2003; Baker et al., 2006; Jayatissa et al., 2006) . In accordance with the literature, present data confirm that rats exposed to CMS procedure consume less sweet food compared to nonstressed rats.
Literature data support the fact that stressed rats had a severe loss of body weight as well as behavioral alterations (Gamaro et al., 2003; Bekris et al., 2005) . Emotional changes, such as exposure to stressful situations can influence feeding behavior, and it has been demonstrated that chronic exposure to stressors may alter body weight of rats (Dess et al., 1988) . In accordance with the literature, our findings also demonstrated loss weight in CMS rats compared to non-stressed rats.
Our findings also observed an increase in adrenal gland weight in those rats exposed to chronic mild unpredictable stress. Distinct authors have already suggested an increase of the rat adrenal weight after 14 (Harro et al., 2001) or 28 days (Konarska et al., 1990) of CMS paradigm. These changes in adrenal gland could be due to the increase of adrenocorticotropin circulating hormone which is released in high concentrations during stressful situations by anterior pituitary gland (O'Connor et al., 2000) .
As stressful life events have a substantial causal association with depression and anxiety, stress paradigms have long been used to model these diseases. Notably, it has been shown that stress can lead to neuronal atrophy and loss in several brain regions, including the hippocampus. The hippocampus plays an important role in the regulation of stress responses and it expresses high levels of BDNF protein and mRNA in the normal adult rat (Conner et al., 1997) . Numerous studies have also documented that stress decreases the expression of BDNF mRNA in the hippocampus (Smith et al., 1995; Russo-Neustadt et al., 2001; Shirayama et al., 2002; Duman and Monteggia, 2006) . Alterations in BDNF synthesis have been suggested to be on the basis of the pathophysiology of depressive states (Tapia-Arancibia et al., 2004) . Here, we showed that rats exposed to the CMS paradigm did not display any alterations in BDNF protein levels in the rat hippocampus.
In humans, BDNF levels are decreased in serum of unmedicated patients suffering from depression (Bergström et al., 2008) . Indeed, low levels of serum BDNF is associated with vulnerability to develop mood disorders in healthy subjects (Karege et al., 2001) . Notably, in the serum of rats exposed to CMS procedure we observed a trend to increase the BDNF protein levels compared to control. Therefore, this lack of alteration (i.e., reduction of increase) in the serum BDNF protein of chronic mild stressed rats could be due to (1) the animal's difference in developing anhedonia behavior, and (2) a neuroprotective mechanism that could be activated in animals which were exposed to stressful situations. To support this view, was reported an upregulation of BDNF mRNA in those CMS-exposed rats, which were resistant to the development of anhedonia (Shirayama et al., 2002) . As far as we are aware, this is the first time that BDNF protein levels were assessed in serum and cerebrospinal fluid of rats subjected to a CMS paradigm. However, we evaluated BDNF protein levels and did not BDNF mRNA as evaluated in other studies. Thus, unlike unmedicated depressive patients, the CMS procedure did not elicit any alteration in rat serum or cerebrospinal fluid BDNF levels.
Despite the anhedonic-related behavior and body weight alterations displayed by rats subjected to CMS paradigm, our findings demonstrated that the exposure to this chronic mild unpredictable stressful situation did not alter BDNF protein levels in serum, cerebrospinal fluid and hippocampus. These findings are contrasting with human observations that showed a correlation between depressive disorders and a decreased Fig. (3) . Effect of CMS paradigm on BDNF protein levels assessed in the hippocampus, cerebrospinal fluid and serum of rats. Bars represent means ± S.E.M. of 15 rats. level of serum BDNF (Karege et al., 2002; Lang et al., 2004; Bergström, 2008) . In fact, our findings reveal that BDNF protein levels were not significantly correlated with the decrease of rats sucrose intake observed in those animals subjected to the CMS paradigm. In recent review article, was described changes on BDNF mRNA levels in hippocampus, but, did not reported studies that sowed decreased in hippocampus BDNF protein levels in stressed rats (Martinowich et al., 2007) .
In conclusion, this study demonstrates that decreased sweet food intake, which reflects an anhedonia-like behavior, was observed in our rats exposed to a CMS paradigm. Despite the behavioral alterations, BDNF protein levels in hippocampus, cerebrospinal fluid and serum were not changed in comparison with control. These observations support in part the view that the CMS paradigm is an animal model of depression which mimics alterations observed in depressive patients, suggesting that stress change only mRNA BDNF levels in analyzed structures.
